Consensus Rallybio Corporation

Equities

RLYB

US75120L1008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1.67 ^USD	+5.03%		+7.05%	-30.13%

May. 15	JPMorgan Downgrades Rallybio to Neutral From Overweight	MT
May. 09	Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Rallybio Corporation

Price target over the last 5 years

History of analyst recommendation changes

6c09effb658583c03c9fb0.dcURkGCYGm5x2KuboS3MxgeHJr3w6h4kgSxJE_n_0Co.F6t34QfWLVk17tzD-VqBoGvWSOShnkR85F5_RJOKj08YqUKkWKxXFji8yA~83c9be41dd3f19b8fc3514259c7ec783

Analyst Recommendations on Rallybio Corporation

JPMorgan Downgrades Rallybio to Neutral From Overweight	May. 15	MT
Wedbush Lowers Rallybio's PT to $11 From $13 After Private Placement, Adjusts Full-Year 2024 Share Count; Maintains Outperform Rating	Apr. 11	MT
HC Wainwright Cuts Rallybio Price Target to $9 From $12, Maintains Buy Rating	Mar. 13	MT
JMP Securities Adjusts Price Target on Rallybio to $8 From $16, Maintains Market Outperform Rating	Feb. 07	MT
Wedbush Adjusts Rallybio's Price Target to $13 From $14, Keeps Outperform Rating	Feb. 07	MT
Jefferies Downgrades Rallybio to Hold From Buy, Adjusts Price Target to $1.50 From $7	Feb. 07	MT
Evercore ISI Cuts Price Target on Rallybio to $15 From $18, Maintains Outperform Rating	Dec. 21	MT
HC Wainwright Trims Rallybio Price Target to $17 From $18, Maintains Buy Rating	Nov. 10	MT
Wedbush Lowers Rallybio's PT to $14 From $16, Retains Cash Runway Guidance But Increases Discount Rate; Maintains Outperform Rating	Nov. 10	MT
JMP Securities Adjusts Price Target on Rallybio to $16 From $26, Maintains Market Outperform Rating	23-06-26	MT
Wedbush Trims Rallybio Price Target to $16 From $17, Maintains Outperform Rating	23-05-09	MT
HC Wainwright Starts Rallybio at Buy With $18 Price Target	23-04-17	MT
Wedbush Starts Rallybio at Outperform With $17 Price Target, Sees 'Favorable' Risk/Reward Setup	23-04-10	MT
JPMorgan Starts Rallybio at Overweight With $21 Price Target	22-12-09	MT
JMP Securities Increases Rallybio's Price Target to $34 From $29, Keeps Market Outperform Rating	22-08-09	MT
JMP Securities Raises Rallybio's Price Target to $34 From $29, Maintains Market Outperform Rating	22-08-09	MT
JMP Securities Adjusts Rallybio's Price Target to $29 From $32, Keeps Market Outperform Rating	22-03-16	MT
JonesTrading Initiates Rallybio at Buy with $30 Price Target	22-03-07	MT
JMP Securities Initiates Rallybio at Market Outperform With $32 Price Target	22-02-22	MT
RALLYBIO : Evercore ISI Initiates Coverage on Rallybio With Outperform Rating, $40 Price Target	21-08-23	MT
RALLYBIO : Cowen Initiates Coverage on Rallybio With Outperform Rating	21-08-23	MT
RALLYBIO : Jefferies Starts Rallybio at Buy With $20 Price Target	21-08-23	MT